Development of H7N9 Influenza Vaccine
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : National Health Research Institutes
Other organizations : National Tsing Hua University, National Chung Hsing University
Variable analysis
- Re-adaptation process of the H7N9 candidate vaccine strains virus (CCVs) (NIBRG-268) to MDCK cells
- Growth of the re-adapted H7N9 CCVs in MDCK cell culture
- Use of OptiPro serum-free medium for MDCK cell growth
- Use of OptiPro medium supplemented with 2 μg/mL TPCK-trypsin for viral replication
- Inactivation of the harvested virus with formaldehyde
- Purification of the virus by clarification and chromatography
- No positive or negative controls were explicitly mentioned in the information provided.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!